Inventor · disambiguated record
Benjamin Maxime Morin
Also filed as: MORIN BENJAMIN MAXIME
8 granted patents·7 pending applications·14 citations·filing 2018–2023
81Inventor score
Files withAGENUS INC15
Top patents by PatentIndex Score
15 records- 0194US11242385B2Anti-CD137 antibodies and methods of use thereofAGENUS INC·Filed 2018·Granted Feb 8, 2022·8 cites·24 claims
- 0285US11692042B2Anti-CD73 antibodies and methods of use thereofAGENUS INC·Filed 2019·Granted Jul 4, 2023·3 cites·22 claims
- 0383US11021537B2Anti-TIGIT antibodies and methods of use thereofAGENUS INC·Filed 2018·Granted Jun 1, 2021·2 cites·70 claims
- 0481US11065317B2Heat shock protein-binding peptide compositions and methods of use thereofAGENUS INC·Filed 2019·Granted Jul 20, 2021·1 cites·43 claims
- 0578US12492393B2Anti-CD137 antibodies and methods of use thereofAGENUS INC·Filed 2021·Granted Dec 9, 2025·0 cites·28 claims
- 0678US2024141047A1Anti-tigit antibodies and methods of use thereofAGENUS INC·Filed 2023·Application pending·0 cites
- 0774US11098117B2Anti-CD137 antibodies and methods of use thereofAGENUS INC·Filed 2020·Granted Aug 24, 2021·0 cites·25 claims
- 0874US2022106581A1Anti-cd137 antibodies and methods of use thereofAGENUS INC·Filed 2021·Application pending·0 cites
- 0970US2023416397A1Anti-cd73 antibodies and methods of use thereofAGENUS INC·Filed 2023·Application pending·0 cites
- 1067US12479913B2Polynucleotide encoding anti-TIGIT and anti-CD96 antibodiesAGENUS INC·Filed 2023·Granted Nov 25, 2025·0 cites·23 claims
- 1165US11718669B2Anti-TIGIT and anti-CD96 antibodiesAGENUS INC·Filed 2022·Granted Aug 8, 2023·0 cites·37 claims
- 1265US2022089732A1Anti-tigit antibodies and methods of use thereofAGENUS INC·Filed 2021·Application pending·0 cites
- 1362US2022008527A1Heat Shock Protein-Binding Peptide Compositions And Methods Of Use ThereofAGENUS INC·Filed 2021·Application pending·0 cites
- 1457US2022257733A1Antigenic polypeptides and methods of use thereofAGENUS INC·Filed 2022·Application pending·0 cites
- 1557US2022275049A1Antigenic polypeptides and methods of use thereofAGENUS INC·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Benjamin Maxime Morin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →